MIM
DGX icon

Macroview Investment Management’s Quest Diagnostics DGX Stock Holding History

Macroview Investment Management’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-2
Closed -$311 – 205
2024
Q3 		$311 Hold
2
– – ﹤0.01% 550
2024
Q2 		$274 Hold
2
– – ﹤0.01% 556
2024
Q1 		$267 Hold
2
– – ﹤0.01% 610
2023
Q4 		$276 Hold
2
– – ﹤0.01% 593
2023
Q3 		$244 Buy
+2
New +$266 ﹤0.01% 757

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $39.1B AUM 28.69% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Macroview Investment Management's DGX Position: Q4 2024 in Review

Macroview Investment Management sold out of Quest Diagnostics (DGX) in Q4 2024, closing a stake of 2 shares — an estimated $311 sold.

Macroview Investment Management first reported a position in DGX in Q3 2023 and held it in 5 quarters. The position peaked at $311 in Q3 2024. 895 funds tracked by Wall St. Rank hold DGX as of Q4 2024.

  • Macroview Investment Management reported no remaining Quest Diagnostics position as of Q4 2024 after selling out during the quarter.
  • Macroview Investment Management sold 2 Quest Diagnostics shares in Q4 2024, an estimated $311.
  • Macroview Investment Management first reported a position in Quest Diagnostics in Q3 2023 and held it in 5 quarters.
  • Macroview Investment Management's Quest Diagnostics position peaked at $311 in Q3 2024.
  • 895 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2024.

Based on Macroview Investment Management's 13F filing for Q4 2024, filed 31 Jan 2025.